ArticleFrontiers in pharmacology2023

Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial.

Niveditha Putananickal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.